TAMARA IVANOVA: Open Payments
NPI 1215491634 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$556 in 27 payments from 10 companies in 2025. Trend: 2023 $593 · 2024 $403 · 2025 $556
Food & beverage: $556
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $147 |
| PFIZER INC. | 8 | $137 |
| Alnylam Pharmaceuticals Inc. | 2 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $44 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
| Boston Scientific Corporation | 1 | $39 |
| Amgen Inc. | 2 | $36 |
| Baxter Healthcare | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| BridgeBio Pharma, Inc. | 1 | $17 |
Products named: LEQVIO, VYNDAQEL, AMVUTTRA, JARDIANCE, ELIQUIS, WATCHMAN FLX, REPATHA, Hillrom - Cardiac Ambulatory Monitor.
Industry payments across VA — which companies pay providers there.
